Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Antigona Tomovici"'
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Disease surveillance is central to the public health understanding of pertussis epidemiology. In Canada, public reporting practices have significantly changed over time, creating challenges in accurately characterizing pertussis e
Externí odkaz:
https://doaj.org/article/2b5004fbeb1c4ed9ae724a5a610ba308
Autor:
Ayman Chit, Hossein Zivaripiran, Thomas Shin, Jason K H Lee, Antigona Tomovici, Denis Macina, David R Johnson, Michael D Decker, Jianhong Wu
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0197970 (2018)
BACKGROUND:Acellular pertussis vaccine studies postulate that waning protection, particularly after the adolescent booster, is a major contributor to the increasing US pertussis incidence. However, these studies reported relative (ie, vs a population
Externí odkaz:
https://doaj.org/article/087d49952e82445aae9689f6251a3198
Publikováno v:
CMAJ Open. 8:E16-E25
Background Understanding the impact of prevention programs on Clostridioides difficile infection rates is important, and decisions on future program changes, including how to use vaccines currently in development, requires a detailed understanding of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b5c1de7b78795cc38e5dd618c77e983
https://doi.org/10.9778/cmajo.20190018
https://doi.org/10.9778/cmajo.20190018
Publikováno v:
CMAJ open. 8(1)
BACKGROUND: Understanding the impact of prevention programs on Clostridioides difficile infection rates is important, and decisions on future program changes, including how to use vaccines currently in development, requires a detailed understanding o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4092a5837cfd5d7c1839f09b62e868ba
https://pubmed.ncbi.nlm.nih.gov/32001435
https://pubmed.ncbi.nlm.nih.gov/32001435
Publikováno v:
Open Forum Infectious Diseases
Background To understand the clinical burden of Clostridioides difficile infection (CDI), we analyzed health outcome data from Ontario, Canada for CDI associated with and manifested in acute care hospitals (ACH), long-term care facilities (LTCF), the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d99ff7eb981018172e50cb8ca90c6587
https://doi.org/10.1093/ofid/ofz523
https://doi.org/10.1093/ofid/ofz523
Autor:
David R. Johnson, Jianhong Wu, Hossein Zivari-Piran, Ayman Chit, Jason Lee, Antigona Tomovici, Michael D. Decker, Thomas Shin, Denis Macina
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 6, p e0197970 (2018)
PLoS ONE, Vol 13, Iss 6, p e0197970 (2018)
Background Acellular pertussis vaccine studies postulate that waning protection, particularly after the adolescent booster, is a major contributor to the increasing US pertussis incidence. However, these studies reported relative (ie, vs a population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6583bf5e4ed2edca1e05cfb16550f21a
http://europepmc.org/articles/PMC6005504
http://europepmc.org/articles/PMC6005504
Publikováno v:
Vaccine. 36(17)
In a prospective, randomized pivotal phase III clinical trial, the immunogenicity and reactogenicity of a tetanus-diphtheria-acellular pertussis vaccine (Tdap) and a tetanus-diphtheria vaccine (Td) vaccine were studied in participants aged 11-64 year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ceddd8a9fba3d772d276bcfbb83e01b
https://pubmed.ncbi.nlm.nih.gov/29573876
https://pubmed.ncbi.nlm.nih.gov/29573876
Autor:
William Meekison, Paul Zickler, Joanne Embree, Marc Dionne, Minran Li, Francisco Diaz-Mitoma, Prakash K. Bhuyan, Earl Rubin, Scott A. Halperin, Antigona Tomovici, Bruce Tapiero, Andrew Lee
Publikováno v:
Pediatric Infectious Disease Journal. 33:73-80
Background Combination diphtheria-tetanus-5 component acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (DTaP5-IPV-Hib-HepB) administered either concurrently with 7-valent pneumococcal conjugate vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::036995a8c1b5c51ba9c5f053e4dce84c
https://doi.org/10.1097/01.inf.0000437806.76221.20
https://doi.org/10.1097/01.inf.0000437806.76221.20
Autor:
Francisco Diaz-Mitoma, Minran Li, Earl Rubin, Prakash K. Bhuyan, Joanne Embree, Scott A. Halperin, Andrew W. Lee, Mark Dionne, Paul Zickler, Antigona Tomovici, Bruce Tapiero, William Meekison
Publikováno v:
Pediatric Infectious Disease Journal. 32:54-61
BACKGROUND DTaP₅-IPV-Hib-HepB, an investigational hexavalent combination vaccine, was evaluated for safety and immunogenicity, when administered to infants with heptavalent pneumococcal conjugate vaccine (PCV7). METHODS Infants were randomized to r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8545ea714a145c5afcb5cad1dfcdc6f
https://doi.org/10.1097/inf.0b013e3182717edf
https://doi.org/10.1097/inf.0b013e3182717edf
Autor:
Francisco Diaz-Mitoma, Joanne M. Langley, Elaine L. Mills, Marc Dionne, Roland Guasparini, Paul Whitstitt, Antigona Tomovici, Bruce Tapiero, Barbara Law, Gerald Predy, Scott A. Halperin
Publikováno v:
Vaccine. 25:1121-1125
In Canada, the fifth dose of the routine childhood immunization schedule against diphtheria, tetanus, pertussis and polio is given at 4-6 years of age. Up to 30% of children may have significant local reactions (redness, swelling) and this may be rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2d9f154b4f7c0c2e784a06cdef44b3b
https://doi.org/10.1016/j.vaccine.2006.09.053
https://doi.org/10.1016/j.vaccine.2006.09.053